As of 2023, around 24 percent of women in the United States reported currently having or being treated for depression, compared to 11 percent of men. This statistic shows the percentage of adults in the United States who currently had or were being treated for depression in 2017 and 2023, by gender.

Based on pharmacy claims of those who filled at least one prescription for mental health medication in 2019, antidepressant use is most prevalent in West Virginia, Kentucky, Vermont, and New Hampshire. This statistic shows the percentage of patients (excluding those on government-sponsored benefits) who filled a prescription for antidepressants in the U.S. in 2019, by state.

Based on pharmacy claims in 2019, more than twice the amount of females than males were taking antidepressants. This statistic shows the percentage of individuals (excluding those on government-sponsored benefits) who filled a prescription for antidepressants in the U.S. in 2019, by age group and gender.

Based on pharmacy claims of those who filled at least one prescription for mental health medication in 2019, nearly twice as many teenage girls take antidepressants compared to teenage boys. This statistic shows the percentage of teenagers (excluding those on government-sponsored benefits) who filled a prescription for antidepressants in the U.S. from 2015 to 2019, by gender.

Globally, antidepressant usage has been on the rise. As of 2023, among select Organization for Economic Cooperation and Development (OECD) countries, Iceland, Portugal, and the UK were the biggest consumers of antidepressants. At that time, people in Iceland consumed antidepressants at a rate of about *** defined daily doses (DDD) per 1,000 people. Mental health globally Mental health disorders affect a significant proportion of the population, though addressing and understanding the prevalence of mental health is difficult due to regional differences in diagnostic criteria and understandings of mental health. Despite barriers to gathering data on mental health, there have been some global quantitative studies to help better understand certain conditions. It is suggested that mental health is among the top three health concerns among adults worldwide. Estimates propose that about ** percent of the overall population suffers from some mental health or substance use disorder. Depression and anxiety A global survey showed that the largest numbers of people with anxiety resided in locations in South-East Asia and the Americas. However, the highest distribution of cases of depression globally is among populations in South-East Asia and the Western Pacific. Both depression and anxiety disproportionately impact women in all regions of the world.

During the 2023-2024 school year, 33 percent of university and college students in the U.S. reported that in the past year they had been using antidepressant medications regularly. This statistic shows the percentage of postsecondary students using psychotropic medications in the United States in 2023-2024.

Based on pharmacy claims of those who filled at least one prescription for mental health medication in 2019, about 50 percent of patients who use a medication for anxiety or insomnia also use an antidepressant. This statistic shows the percentage of patients (excluding those on government-sponsored benefits) in the U.S who filled a prescription for antidepressants in addition to other select medications in 2019, by condition.

This statistic explains prescription antidepressant drug use in the past month in selected periods between 1988 and 2014, in the United States. Between 1988 and 1994, the share of prescription antidepressant drug users among the total population was 1.8 percent.

Based on pharmacy claims in 2019, the highest prevalence of anti-anxiety medication use was seen among women aged 45 to 64 years, with around 10 percent filling at least one prescription in 2019, twice the rate seen among men in the same age group. This statistic shows the percentage of individuals (excluding those on government-sponsored benefits) who filled a prescription for anti-anxiety medication in the U.S. in 2019, by age group and gender.

In 2022, there were an estimated ***** overdose deaths in the U.S. from antidepressants, an increase from ***** deaths in 2000. This statistic presents the number of overdose deaths from antidepressants in the U.S. from 1999 to 2022.

This graph shows the percentage of U.S. Iraq and Afghanistan veterans who had been prescribed and were currently taking selected medications for service-related injury as of 2021. It was found that 75 percent of respondents were taking anti-depressant medication for service-related injury.

This statistic depicts the percentage of adolescents in the United States, between the ages of ** and **, who have taken psychotropic medication in the past month between 2005 and 2010, by type. Of those surveyed, *** percent of adolescents reported taking antidepressants in the last month. Psychotropic medication is used to treat clinical psychiatric symptoms or mental disorders such as depression.

This statistic shows the number of Medicaid dispensed retail prescriptions for antidepressants from 2013 to 2015 in the United States per year, sorted by most common products. In 2014, generic drug Sertraline was prescribed **** million times to Medicaid patients. Medicaid is an optional plan for the United States. Enrollment for this plan is expected to increase after provisions from the Affordable Care Act that established an minimum eligibility threshold at *** percent of the federal poverty level.

This statistic displays the percentage of adolescents aged 12 to 17 in the United States who have received nonmedication mental health services for serious emotional or behavioral difficulties within the last six months, by gender from 2010 to 2012. During these years, 5.4 percent of boys between 12 and 17 years old received nonmedication mental health services.

Nonmedication mental health services

In the United States, 5.4 percent of adolescent boys and 3.2 percent of adolescent girls have received nonmedication mental health services for serious emotional or behavioral difficulties within the past six months from 2010 to 2012. Such behavioral and emotional difficulties are defined in the United States by characteristics such as difficulty to maintain interpersonal relationships with peers and teachers or a general mood of unhappiness or depression that negatively impacts the child’s education. These disorders can also be differentiated between internalizing disorders and externalizing disorders. A child with internalizing disorders may experience depression, or loss of interest in daily activities. Children with externalizing disorders tend to be extroverted or act out and include conditions such as attention deficit hyperactivity disorder (ADHD). In adolescents between 12 and 19 years old in the United States, 3.2 percent have used antidepressants in the last six months and 3.2 percent have used ADHD medication.

Adolescent boys tend to be more likely than girls to have a serious emotional or behavioral difficulty and are also more likely to receive nonmedication health services. Services can be offered within school and nonschool settings in the country. About 52 percent of boys with these difficulties have received treatment or counseling within their regular schools. Within an office, clinic, or a center setting, 41.4 percent of boys and 38.2 percent of girls have received nonmedication mental health services.

In 2004, sertraline was prescribed over 28 million times. In comparison, in 2022, the last year with available data, the number of prescriptions for sertraline was nearly 40 million. Sertraline is primarily used as an antidepressant of the selective serotonin reuptake inhibitor (SSRI) class. This statistic shows the total annual number of sertraline prescriptions in the U.S. from 2004 to 2022, in millions.

This statistic depicts the percentage of adolescents in the United States, between the ages of 12 and 19, who have taken psychotropic medication in the past month between 2005 and 2010, by sex. Of those surveyed, 4.5 percent of female adolescents reported taking antidepressants in the last month. Psychotropic medication is used to treat clinical psychiatric symptoms or mental disorders such as depression.

In Ireland, the United Kingdom, and Italy, over **** of respondents to a survey in 2022 reported to be experiencing stress. Furthermore, close to ******* of respondents in most surveyed countries reported suffering from depression. Feelings of anxiety were highest in Germany, at **** percent. Depression in Europe Depression can affect anyone, however, there are some demographics that are more at risk. Typically, younger individuals have a higher risk of suffering from depression, as well as women and people with financial difficulties. Poland, followed by Greece and Cyprus, were the European countries with the highest share of adults at risk of depression in the EU in 2022. Direct costs of depression The direct costs of depression include the cost of medicines and medical professionals. The spending on antidepressant drugs varies greatly across European countries. Germany, the country with the largest population in Europe, sustained the highest spending in 2020 compared to other European countries, with *** million U.S. dollars.